Human umbilical cord vein allograft arteriovenous fistula for chemotherapy access.
Seven patients who received chronic chemotherapy and required vascular access underwent construction of an arteriovenous fistula of the leg using gluteraldehyde-tanned human umbilical cord vein allografts. No wound or graft complications have occurred and patient tolerance of the operative procedure and subsequent use of the fisulas for chemotherapy has been excellent. Our preliminary results suggest that the use of umbilical vein allograft arteriovenous fistulas is quite satisfactory for long-term chemotherapy access.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001166:Arteriovenous Shunt, Surgical / Q000379:methods*; D001705:Bioprosthesis; D005260:Female; D005263:Femoral Artery / Q000601:surgery; D005268:Femoral Vein / Q000601:surgery; D006801:Humans; D007866:Leg / Q000098:blood supply; D008875:Middle Aged; D011183:Postoperative Complications; D012039:Regional Blood Flow; D014184:Transplantation, Homologous; D014471:Umbilical Veins / Q000637:transplantation*
D000970:Antineoplastic Agents